openPR Logo
Press release

Global Irritable Bowel Syndrome with Constipation Market at a CAGR of 6.8% during 2016-2022

04-27-2016 12:45 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Credence Research Inc

Global Irritable Bowel Syndrome with Constipation Market at

Lubiprostone to Lead the Global Irritable Bowel Syndrome with Constipation Market at a CAGR of 6.8% during 2016-2022

The latest market report published by Credence Research, Inc. “Global Irritable Bowel Syndrome with Constipation (IBS-C) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the irritable bowel syndrome with constipation (IBS-C) drugs market was valued at USD 1,045 Mn in 2015, and is expected to reach USD 1,597.5 Mn by 2022, expanding at a CAGR of 6.3% from 2016 to 2022.

Browse the full report Irritable Bowel Syndrome with Constipation (IBS-C) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/irritable-bowel-syndrome-with-constipation-drugs-market

Market Insights

The global IBS-C drugs market is expected to progress at a CAGR of 6.3% during the forecast period. Europe is expected to be the largest regional market for IBS-C drugs followed by North America and Asia Pacific. Gradual growth in physician and patient awareness corresponding to the perpetual growth in disease prevalence are the major growth contributors to the global IBS-C market.

The global IBS-C drugs market is expected to witness significant growth over the forecast period due to significant adoption of IBS drugs. The recent FDA approvals and currently successful clinical trials of IBS drugs will further surge the market. Growing geriatric population and rise in healthcare expenditure are further creating huge scope for IBS-C drugs market. IBS-C is much prevalent in developed world, where dietary habits, work conditions, and similar such factors contribute to higher risk of lifestyle-related gastrointestinal diseases.

For More Reports To similar category @ http://www.credenceresearch.com/industry/pharmaceuticals-market

Among the regional markets, Europe is expected to lead the global market in terms of revenue share, expected to reach USD 639 Mn in 2022. Asia Pacific is the most emerging market and is expected to contribute significantly during the forecast period and will undergo progress corresponding to the global trends. The major players in the global IBS-C market include Sucampo AG, Activis, Cardinal Health, Catelent Pharma Solutions, Synergy Pharmaceuticals and others. Rapid commercialization, strong R&D activities, market consolidation strategies brought up by these players will be the major progressive features of the market. Introduction of highly targeted, orally administered peripherally acting mu-opioid receptor antagonist (PAMORA) therapies has also been a key market event.

Drugs such as lubiprostone, methylnaltrexone ad others are widely used for treating IBS-C in North America., thus addressing symptoms such as stomach pain or cramps, bloating, and infrequent or difficult passage of stool. Adoption of these drugs is further higher among elderly population.

Though rare, some probable side effects of these drugs include nausea, further stomach pain, swelling on face, tightness in throat, and others. Majority of IBS-C drugs are widely accepted and the rise in FDA approvals to newer drugs are adding up to create further market opportunities. As a result, several market players are increasingly focusing on research and development activities to come with better and novel pharmaceutical solutions for treating IBS-C.

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Irritable Bowel Syndrome with Constipation Market at a CAGR of 6.8% during 2016-2022 here

News-ID: 336209 • Views:

More Releases from Credence Research Inc

Automated E Commerce Packaging Market Projected to Hit USD 1671.2 Million by 2032, Expanding at 13.9 % CAGR: Credence Research
Automated E Commerce Packaging Market Projected to Hit USD 1671.2 Million by 203 …
Market Outlook The Automated E-Commerce Packaging Market is set for steady expansion as online retail activity grows and brands seek faster fulfillment. The market reached USD 590 million in 2024 and is expected to reach USD 1,671.2 million by 2032, posting a 13.9% CAGR. Growth accelerates as retailers automate packing lines to reduce labor strain, limit material waste, and manage seasonal order peaks. Demand strengthens in apparel, electronics, and fast-moving consumer
Fish-Oil-Based-Drugs-Market to Reach USD 7690 million by 2032 at 6% CAGR - Credence Research
Fish-Oil-Based-Drugs-Market to Reach USD 7690 million by 2032 at 6% CAGR - Crede …
Market Overview: The Fish-oil-based-drugs market size was valued at USD 4825 million in 2024 and is anticipated to reach USD 7690 million by 2032, at a CAGR of 6% during the forecast period. Demand rises due to wider awareness of omega-3 benefits. Drug makers expand production to meet clinical needs across chronic disease groups. Rising cases of heart disorders push the use of fish-oil-based drugs across global care systems. Doctors recommend these
Web Application Firewall Market to Reach USD 13714.8 million by 2032 at 14.4% CAGR - Credence Research
Web Application Firewall Market to Reach USD 13714.8 million by 2032 at 14.4% CA …
Web Application Firewall Market to Reach USD 13714.8 million by 2032 at 14.4% CAGR - Credence Research Market Overview The Web Application Firewall Market is projected to grow from USD 4675 million in 2024 to an estimated USD 13714.8 million by 2032, with a compound annual growth rate (CAGR) of 14.4% from 2024 to 2032. Strong demand for advanced threat protection drives steady adoption across enterprises. Businesses face rising risks from bot attacks,
Interactive-media-market Market to Reach USD 525.9 million by 2032 at 14.4% CAGR - Credence Research
Interactive-media-market Market to Reach USD 525.9 million by 2032 at 14.4% CAGR …
Market Overview The Interactive-media-market size was valued at USD 179.27 million in 2024 and is projected to reach USD 525.9 million by 2032, growing at a CAGR of 14.4% through the forecast period. The sector expands due to strong demand for digital experiences. Brands invest more in immersive content to boost customer engagement. Rapid adoption of AR tools, VR environments, and gamified content pushes new growth. Companies use interactive formats to improve

All 5 Releases


More Releases for IBS

Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs. 👉 Download our latest market insights:
IBS Implant Market Research Report 2023 - Valuates reports
The global IBS Implant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Get Sample report - https://reports.valuates.com/request/sample/QYRE-Auto-35O11417/Global_IBS_Implant_Market_Research_Report_2022 North American market for IBS Implant is estimated to increase from $ million in 2023 to reach $ million by 2029, at
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide. A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped